Medical Insights with Dr. Thomas Blom

In this episode Dr. Blom is joined by Dr. Amit Mehta, a practicing oncologist from North Carolina with extensive expertise in prostate cancer. Together, they demystify metastatic prostate cancer from the patient's perspective, answering the most pressing questions about diagnosis, advanced treatment options, and navigating daily lifestyle changes.

Key Takeaways

Discover the fundamental differences between imaging modalities, including CT scans, bone scans, and PSMA PET scans, to accurately stage the disease.

Learn how genetic testing, particularly for the BRCA2 gene, not only assesses hereditary risk for family members but also opens doors to targeted combination therapies that significantly extend treatment efficacy.

Understand the critical importance of continuous androgen deprivation therapy and why maintaining suppressed testosterone levels maximizes long-term survival odds.

Master actionable nutritional strategies supported by medical data, such as incorporating green tea and vitamin D while avoiding whole milk, to complement your prescribed medical treatments.

Get to know Dr. Thomas Blom, a board-certified oncologist and hematologist serving the greater Princeton New Jersey region, as he launches a new podcast to demystify complex cancer care. In this premier episode, podcast producer Kenneth Greenberg introduces Dr. Blom who discusses the doctor-patient relationship, offering a rare, behind-the-scenes look at how physicians approach life-altering diagnoses and formulate actionable treatment plans.

• Discover what drives a physician's passion for hematology and oncology through decades of rapid medical advancements.
• Learn effective strategies for digesting complex medical information, including why receiving difficult news over the phone at home can give patients the necessary space to process.
• Master the expectations of patient care by understanding how specialized oncologists prioritize straightforward communication and immediate treatment options.
• Explore the crucial upcoming discussions planned for patients and families, ranging from managing complications like "chemo brain" and neuropathy, to navigating chronic lymphocytic leukemia and end-of-life care.